BioGend Therapeutics Co Ltd

NEW
ROCO:6733 (Taiwan)   Ordinary Shares
NT$ 26.9 +1.05 (+4.06%) Aug 28
At Loss
P/B:
3.39
Market Cap:
NT$ 3.61B ($ 114.20M)
Enterprise V:
NT$ 2.78B ($ 87.88M)
Volume:
196.05K
Avg Vol (2M):
189.68K
Trade In:
Volume:
196.05K
At Loss
Avg Vol (2M):
189.68K

BioGend Therapeutics Co Ltd Operating Data

BioGend Therapeutics Co Ltd Competitors' Latest Operating Data

Operating data not available.

BioGend Therapeutics Co Ltd (ROCO:6733) Operating Data Charts